Literature DB >> 16406421

CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women.

Fabiana Siqueira Ribeiro1, Lídia Maria da Fonte de Amorim, Tatiana de Almeida Simão, Gulnar Azevedo Mendonça, Cláudia Vitória de Moura Gallo, Luis Felipe Ribeiro Pinto.   

Abstract

A prolonged or increased exposure to endogenous estrogens associated with genetic factors are considered to be the main risk factors for breast cancer. The CYP19 gene encodes the enzyme aromatase, which catalyzes the conversion of androgens into estrogens. CYP19 alleles containing different numbers of tetranucleotide TTTA repeats in intron 4 have been associated with increased breast cancer risk. In this study we investigated, for the first time, the frequency of CYP19 (TTTA)n alleles in a South American population (n = 475) and analyzed the risk for developing breast cancer in a case-control study comprising 135 cases and 270 age-matched controls. It is shown that Brazilians possess not only the alleles identified in all the other populations studied so far (alleles containing from 7 to 13 TTTA repeats), but also the (TTTA)6 allele, that had never been described before. The (TTTA)10 allele was three times more frequent in cases when compared to controls and presented a significant positive association (p = 0.048) with breast cancer development in Brazilians.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406421     DOI: 10.1016/j.toxlet.2005.11.014

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.

Authors:  Zaida Garcia-Casado; Angel Guerrero-Zotano; Antonio Llombart-Cussac; Ana Calatrava; Antonio Fernandez-Serra; Amparo Ruiz-Simon; Joaquin Gavila; Miguel A Climent; Sergio Almenar; Jose Cervera-Deval; Josefina Campos; Carlos Vazquez Albaladejo; Antonio Llombart-Bosch; Vicente Guillem; Jose A Lopez-Guerrero
Journal:  BMC Cancer       Date:  2010-02-09       Impact factor: 4.430

2.  Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.

Authors:  Chu Chen; Lori C Sakoda; Jennifer A Doherty; Melissa M Loomis; Sherianne Fish; Roberta M Ray; Ming Gang Lin; Wenhong Fan; Lue Ping Zhao; Dao Li Gao; Helge Stalsberg; Ziding Feng; David B Thomas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

3.  Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women.

Authors:  Blanca Murillo-Ortiz; Sandra Martínez-Garza; David Suárez García; Rosa Del Carmen Castillo Valenzuela; Juan Francisco García Regalado; Gerardo Cano Velázquez
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-01-13

4.  Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women.

Authors:  Jia-Li Jin; Jing Sun; Hui-Juan Ge; Yun-Xia Cao; Xiao-Ke Wu; Feng-Jing Liang; Hai-Xiang Sun; Lu Ke; Long Yi; Zhi-Wei Wu; Yong Wang
Journal:  BMC Med Genet       Date:  2009-12-16       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.